Complementary and alternative medicines in cancer patients

被引：15

作者：

Bosacki, Claire ^{[1
]}

Vallard, Alexis ^{[1
]}

Gras, Mathilde ^{[2
]}

Daguenet, Elisabeth ^{[2
]}

Morisson, Stephanie ^{[3
]}

Mery, Benoite ^{[4
]}

Jmour, Omar ^{[1
]}

Guy, Jean-Baptiste ^{[1
]}

Magne, Nicolas ^{[1
]}

机构：

[1] Inst Cancerol Lucien Neuwirth, Dept Radiotherapie, 108 Bis,Ave Albert Raimond,BP 60008, F-42271 St Priest En Jarez, France

[2] Inst Cancerol Lucien Neuwirth, Dept Univ Rech & Educ, 108 Bis,Ave Albert Raimond,BP 60008, F-42271 St Priest En Jarez, France

[3] Inst Cancerol Lucien Neuwirth, Dept Interdisciplinaire Soins Support Patient Onc, 108 Bis,Ave Albert Raimond,BP 60008, F-42271 St Priest En Jarez, France

[4] Inst Cancerol Lucien Neuwirth, Dept Oncol Med, 108 Bis,Ave Albert Raimond,BP 60008, F-42271 St Priest En Jarez, France

来源：

BULLETIN DU CANCER | 2019年 / 106卷 / 05期

关键词：

Complementary and alternative medicines; Unconventional care practices; Cancer; Level of evidence; Literature review; Supportive care; Assessment of practices; QUALITY-OF-LIFE; BREAST-CANCER; HYPNOSIS INTERVENTION; HOMEOPATHY; PAIN; SYMPTOMS; THERAPY; TRIAL; CHEMOTHERAPY; METAANALYSIS;

D O I：

10.1016/j.bulcan.2019.02.011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Complementary and alternative medicines (CAMs) play more and more a significant role both in France and all over the world. Yet, their definition and their role in cancer treatments legitimately raise concerns. This article aims at establishing a picture of the CAMs admitted by the French Medical Board as well as those which are new or in common medical practices in France. We start with a brief reminder of their origin, their status and how they are used. Then, we review the literature about some of the best clinical trials using CAMs in cancer patients. To finish, we try to understand what makes CAMs so thrilling, but also why they create controversy and which common points they may have with conventional medicine.

引用

页码：479 / 491

页数：13

共 50 条

[31] Complementary medicines: an alternative view
Gibson, Carl
[J]. AUSTRALIAN PRESCRIBER, 2022, 45 (01) : 8 - 8
[32] Enquiring about cancer patients' use of complementary and alternative medicines: Is our job done?
Robotin, Monica
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (04) : 245 - 247
[33] Concerns with complementary and alternative medicines
Appadurai, IR
Hanna, CL
[J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2006, 23 (05) : 441 - 442
[34] Perspectives on Complementary and Alternative Medicines
McClelland, Angela
[J]. CANCER FORUM, 2012, 36 (01) : 61 - 61
[35] Use of Complementary and Alternative Medicines among Cancer Patients: A Single-Center Study
Gras, Mathilde
Vallard, Alexis
Brosse, Christelle
Beneton, Aurelie
Sotton, Sandrine
Guyotat, Denis
Fournel, Pierre
Daguenet, Elisabeth
Magne, Nicolas
Morisson, Stephanie
[J]. ONCOLOGY, 2019, 97 (01) : 18 - 25
[36] Complementary and Alternative Medicines in Prostate Cancer: From Bench to Bedside?
Klempner, Samuel J.
Bubley, Glenn
[J]. ONCOLOGIST, 2012, 17 (06): : 830 - 837
[37] Complementary and alternative medicines for use in supportive care in pediatric cancer
Kelly, Kara M.
[J]. SUPPORTIVE CARE IN CANCER, 2007, 15 (04) : 457 - 460
[38] Complementary and alternative medicines for use in supportive care in pediatric cancer
Kara M. Kelly
[J]. Supportive Care in Cancer, 2007, 15 : 457 - 460
[39] Complementary and alternative medicines during cancer treatments in the United States
Schneider, M.
[J]. ONCOLOGIE, 2007, 9 (01) : 64 - 65
[40] USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINES (CAM) IN DIABETICS PATIENTS IN QUETTA
ul Haq, N.
Saeed, S.
Iqbal, Q.
Naseem, A.
Razaq, G.
Farooqui, M.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A865 - A865

← 1 2 3 4 5 →